REFERENCES
- Allen RH, Seetharam B, Podell E et al.: Effect of proteolytic enzymes on the binding of cobalamin to R protein and intrinsic factor. J Clin Invest 61: 47–54, 1978.
- Berkow R, Fletcher AJ, Eds: Vitamin B12 deficiency. In The Merck Manual of Diagnosis and Therapy, pp. 937–938. Merck, Philadelphia, 1988.
- Berkow R, Fletcher AJ, Eds: Anemia due to vitamin B12 deficiency. In The Merck Manual of Diagnosis and Therapy, pp. 1109–1111. Merck, Philadelphia, 1988.
- Takimoto G, Yoshimatsu K, Isomura J et al.: Immunomodulation by methyl-B12. Igaku no Ayumi 112: 588–590, 1980 (in Japanese).
- Sakane T, Takada S, Kotani H et al.: Effects of methyl-B12 on the in vitro immune functions of human T lymphocytes. J Clin Immunol 2: 101–109, 1982.
- June CH, Ledbetter JA, Linsley PS et al.: Role of the CD28 receptor in T-cell activation. Immunol Today 11: 211–216, 1990.
- Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14: 233–258, 1996.
- Fraser JD, Irving BA, Crabtree GR et al.: Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251: 313–316, 1991.
- Schwartz RH: Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065–1068, 1992.
- Linsley PS, Brady W, Grosmaire L et al.: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 m RNA accumulation. J Exp Med 173: 721–730, 1991.
- Arnett FC, Edworthy SM, Bloch DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324, 1988.
- Sakane T, Takada S, Suzuki N et al.: Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells. J Immunol 137: 2809–3813, 1986.
- Sakane T, Murakawa Y, Takeno M et al.: T cell interactions in active rheumatoid arthritis: insights from the human autologous mixed lymphocyte reaction as a model of T cell activation cascade. Clin Exp Immunol 85: 55–60, 1991.
- Nagafuchi H, Suzuki N, Mizushima Y et al: Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J Immunol 151: 6252–6534, 1993.
- June CH, Fletcher MC, Ledbetter JA et al.: Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J Immunol 144: 1591–1599, 1990.
- Trenthame DE, Dynesius RA, David JR: Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest 62: 359–366, 1978.
- Forre O, Bjerkhoel F, Salvesen CF et al.: An open, controlled, randomized comparison of cyclosporin and azathioprine in the treatment of rheumatoid arthritis: a preliminary report. Arthritis Rheum 30: 88–92, 1987.
- Moreland LW, Buey RP, Tilden A et al: Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum 36: 307–318, 1993.
- Kotzin B, Straber S, Engleman EG et al: Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med 305: 969–982, 1981.
- Linsley JD, Brady M, Urnes M et al.: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174: 561–569, 1991.
- Harding FA, McArthur JG, Gross JA et al: CD28-mediated signaling co-stimulated murine T cells and prevents induction of anergy in T cell clones. Nature 356: 607–609, 1992.
- Freeman GKJ, Gribben JG, Boussiotis VA et al: Cloning of B7-2: A CTLA-4 conter-receptor that costimulates human T cell proliferation. Science 262: 909–911, 1993.
- Webb LMC, Walmsley MJ, Feldmann M: Prevention and amekioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 26: 2320–2328, 1996.
- Finck BK, Linsley PS, Wofsy D: Treatment of murine lupus with CTLA4Ig. Science 265: 1225–1227, 1994.
- Russell ME, Hancock WW, Akalin E et al: Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 97: 833–838, 1996.